OWINGS MILLS, Md., April 20, 2018 /PRNewswire/ -- Medifast,
Inc. (NYSE: MED), a leading manufacturer and distributor of
clinically proven, healthy living products and programs, will
announce financial results for the first quarter ended March 31, 2018 on Thursday, May 3, 2018, after market close. The
Company will host a conference call to discuss these results with
additional comments and details. Participants from the Company will
be Daniel R. Chard, Chief Executive
Officer, and Timothy Robinson, Chief
Financial Officer.
The conference call is scheduled to begin at 4:30 p.m. ET on May 3,
2018. The call will be broadcast live over the Internet
hosted at the Investor Relations section of Medifast's website at
www.MedifastInc.com, and will be archived online through
May 17, 2018. In addition, listeners
may dial (855) 560-2579.
A telephonic playback will be available from 6:30 p.m. ET, May 3,
2018, through May 10, 2018.
Participants can dial (877) 344-7529 to hear the playback and enter
passcode 10119661.
About Medifast®:
Medifast (NYSE: MED) is a leading manufacturer and distributor
of clinically proven, healthy living products and programs. The
brand has been recommended by more than 20,000 Doctors since its
founding. In 2016, the company announced OPTAVIA®, an
exclusive brand and product line sold through its community of
independent Coaches who offer support and guidance to their
Clients. In partnership with OPTAVIA Coaches, franchise
partners, and its Scientific Advisory Board, Medifast offers
comprehensive wellness products and programs that focus on creating
sustainable change by helping people learn to incorporate healthy
habits into their lives. Medifast is traded on the New York Stock
Exchange and was named to Forbes' 100 Most Trustworthy Companies in
America List in 2016 and 2017. For
more information, visit www.MedifastInc.com or
www.OPTAVIA.com.
MED-F
View original content with
multimedia:http://www.prnewswire.com/news-releases/medifast-inc-to-announce-financial-results-for-the-first-quarter-ended-march-31-2018-300633704.html
SOURCE Medifast, Inc.